The Safety and Effectiveness of rhTSH in Radioiodine Treatment for Patients With Differentiated Thyroid Cancer.
Status:
Recruiting
Trial end date:
2021-10-01
Target enrollment:
Participant gender:
Summary
This is a randomized, open, parallel controlled, multi-center clinical trial; 120 subjects
were randomly assigned to the test group and the control group according to 3:1.